1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

21 Jan 2020
Admin
News Article

Strides Arm Receives Eir For Its Us Facility

Strides Pharma Science Ltd (Strides) On Monday Said Its Arm Has Received An Establishment Inspection Report (Eir) From The Us Health Regulator For Its Florida Facility In The Us. Strides Pharma Inc Received Eir From The United States Food And Drug Administration (Usfda) For The Inspection Conducted At Its Unit It December Last Year."Strides Today Announced That Its Step Down Subsidiary, Strides Pharma Inc. (Spi), Has Received An Establishment Inspection Report (Eir) From The Usfda For Its Facility In Riviera Beach, Florida, Us," It Said In A Filing To The Bse.The Facility Is One Of The Very Few Manufacturing Facilities In The Us With A Soft Gel Capsule (Sgc) Manufacturing Suite For Formulations With Containment Needs, It Said.Strides Has A Portfolio Of Approved Sgcs In The Us And Other Regulated Markets The Inspection Outcome Will Bolster The Company'S Fast-Growing Sgc Franchise In The Us And Will Also Help Accelerate Our Foray Into The Private Label Opportunity With 'In Market For Market' Products," The Filing Said.Strides Will Kickstart The Site Transfers Of Its Existing Sgc Portfolio To The Site With Immediate Effect.In The Future, The Company Said, It Plans To Expand Additional Dosage Format Suites At The Florida Facility, Which Will Mirror The Capabilities Of Its Formulations Facility In Singapore And Will Help The Company To Tap Opportunities Under Various Federal Government Procurement Programmes, Including Procurements Administered By The Department Of Veterans Affairs.Shares Of Strides Pharma Science Were Trading 0.96 Per Cent Higher At Rs 390.50 Apiece On The Bse In Morning Trade.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!